170237 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; DNA viruses; Herpetoviridae, e.g. pseudorabies virus Epstein-Barr virus
DETECTION OF ANTI-VIRAL CDR3s IN CANCER
#2Assay for Early Detection of Nasopharyngeal Carcinoma
#3METHODS AND SYSTEMS FOR TUMOR DETECTION
#4THERMODYNAMIC PREDICTION
#5Methods and compositions for assessing antibody specificities
#6ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION
#7Methods and compositions for assessing antibody specificities
#8POLYPEPTIDE ENCODED BY EB VIRUS BNLF2B GENE AND USE THEREOF IN DETECTION
#9NOVEL ANTIBODIES FOR DETECTING EPSTEIN BARR VIRUS-POSITIVE GASTRIC CANCER
#10SYSTEMS AND METHODS FOR DETECTING SUBSTANCES IN A FLUID USING TAPERED FIBERS
#11METHOD FOR DIAGNOSING AND STAGING HERPESVIRUS-MEDIATED NEURODEGENERATION
#12Methods of Selecting T Cell Line and Donor Thereof for Adoptive Cellular Therapy
#13Classification and Treatment of Gastric Cancer
#14Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses
#15Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection
#16Methods and compositions for assessing antibody specificities
#17METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES
#18Antibody to Epstein Barr Virus and Uses Thereof
#19Virus-like particle compositions and vaccines against epstein-barr virus infection and disease
#20Zinc-binder based EBNA1-specific compounds
#21Sweat as a biofluid for analysis and disease identification
#22Detection of bioagents using a shear horizontal surface acoustic wave biosensor
#23Classification and Treatment of Gastric Cancer
#24Methods and systems for tumor detection
#25Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease
#26Methods of selecting T cell line and donor thereof for adoptive cellular therapy
#27Method for treating epstein-barr virus—positive cancer with immunotherapy
#28Method of diagnosing and treating Epstein Barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
#29METHOD OF DIAGNOSING AND TREATING EPSTEIN BARR VIRUS-BASED MYALGIC ENCEPHALOMYELITIS CHRONIC FATIGUE SYNDROME PATIENTS USING A SERUM ANTIBODY ASSAY
#30EBV PROTEINS AS MARKERS IN METHODS OF DIAGNOSING CHRONIC FATIGUE SYNDROME (CFS)
#31Cell model for neovascular diseases using EBV-infected human corneal epithelial cells
#32Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients
#33METHOD OF DIAGNOSING AND TREATING EPSTEIN BARR VIRUS-BASED MYALGIC ENCEPHALOMYELITIS CHRONIC FATIGUE SYNDROME PATIENTS
#34USE OF HISTONES FOR THE EARLY DIAGNOSIS AND/OR PREVENTIVE THERAPY OF VIRALLY-INFECTED LIVING CELLS AND A BIOCHIP FOR CARRYING OUT SAID DIAGNOSIS
#35Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof
#36MEDICINAL AGENT FOR DISEASE ASSOCIATED WITH EPSTEIN-BARR VIRUS, AND METHOD FOR SCREENING OF THE MEDICINAL AGENT
#37Screening methods for detection of susceptibility to leukemia and lymphomas
#38USE OF SYNTHETIC PEPTIDE DERIVED FROM ZEBRA PROTEIN FOR THE IN VITRO DIAGNOSIS OF THE EPSTEIN-BARR VIRUS (EBV) REACTIVATION
#39METHOD AND KIT FOR DETECTION/IDENTIFICATION OF VIRUS-INFECTED CELL
#40Detection of bioagents using a shear horizontal surface acoustic wave biosensor
#41MEDICINAL AGENT FOR DISEASE ASSOCIATED WITH EPSTEIN-BARR VIRUS, AND METHOD FOR SCREENING OF THE MEDICINAL AGENT
#42Detection of primary infections with pathogens
#43Test Device for the In-Vitro Diagnosis of Multi-Analyte Tests and Use Thereof
#44Materials and methods for inductions of immune tolerance
#45Saliva immunoassay for detection of exposure to infectious agents
#46Biochip kit comprising biochip based on antigen-antibody reactions, and its usage